TrueMark Investments LLC Makes New $3.46 Million Investment in UnitedHealth Group Incorporated $UNH

TrueMark Investments LLC bought a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm bought 10,465 shares of the healthcare conglomerate’s stock, valued at approximately $3,455,000.

A number of other hedge funds also recently bought and sold shares of UNH. Stegent Equity Advisors Inc. acquired a new stake in UnitedHealth Group in the fourth quarter valued at approximately $327,000. Congress Park Capital LLC lifted its position in shares of UnitedHealth Group by 3.0% during the 4th quarter. Congress Park Capital LLC now owns 3,475 shares of the healthcare conglomerate’s stock valued at $1,147,000 after buying an additional 100 shares in the last quarter. Moisand Fitzgerald Tamayo LLC increased its holdings in UnitedHealth Group by 46.5% in the 4th quarter. Moisand Fitzgerald Tamayo LLC now owns 331 shares of the healthcare conglomerate’s stock worth $109,000 after acquiring an additional 105 shares in the last quarter. Enterprise Financial Services Corp lifted its holdings in UnitedHealth Group by 9.6% during the fourth quarter. Enterprise Financial Services Corp now owns 1,492 shares of the healthcare conglomerate’s stock valued at $493,000 after purchasing an additional 131 shares in the last quarter. Finally, Beacon Investment Advisory Services Inc. grew its position in shares of UnitedHealth Group by 12.0% in the fourth quarter. Beacon Investment Advisory Services Inc. now owns 2,170 shares of the healthcare conglomerate’s stock valued at $716,000 after purchasing an additional 232 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Trending Headlines about UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: UnitedHealthcare rolled out Avery, a generative AI companion aimed at simplifying member navigation, improving self‑serve capabilities and helping customer advocates handle requests more efficiently—this could boost engagement, lower service costs and improve retention if adoption scales. UnitedHealthcare introduces Avery generative AI companion
• Positive Sentiment: Analyst commentary highlights Avery’s potential to “redefine healthcare navigation at scale,” reinforcing the strategic case that AI-driven workflows could materially improve member experience and operational efficiency over time. Can UnitedHealth’s Avery Redefine Healthcare Navigation at Scale?
• Positive Sentiment: Erste Group nudged up its FY2027 EPS forecast slightly, suggesting some analyst conviction in UnitedHealth’s earnings trajectory despite recent volatility. Small estimate upgrades can support the longer‑term earnings story. UNH Valuation / Analyst Note (MarketBeat)
• Neutral Sentiment: Several outlets note analysts’ average rating as “Moderate Buy,” indicating consensus caution rather than strong conviction; useful context for positioning but not an immediate catalyst. UnitedHealth Given Average Rating of “Moderate Buy” by Analysts
• Neutral Sentiment: Zacks flagged UNH as a trending stock, summarizing factors investors should watch (scale, guidance, valuation) — informative for sentiment monitoring rather than a direct price driver. UNH Is a Trending Stock: Facts to Know
• Neutral Sentiment: Coverage in a mega‑cap roundup highlights UNH’s dominant position and limited upside from scale—useful framing for portfolio managers evaluating risk/return among large-cap names. 1 Mega-Cap Stock with Exciting Potential and 2 We Question
• Negative Sentiment: Analysts expect a single‑digit profit decline in UnitedHealth’s upcoming fiscal Q1 report, which can pressure near‑term multiples and sentiment if results follow the projection. Here’s What to Expect From UnitedHealth’s Next Earnings Report
• Negative Sentiment: Recent coverage pointing to weak recent share performance and a valuation check highlights market concern over the stock’s discount from prior highs and whether growth can reaccelerate—a likely contributor to today’s sell‑off. UnitedHealth Group (UNH) Valuation Check After Recent Weak Share Performance

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on UNH. Sanford C. Bernstein reaffirmed an “outperform” rating on shares of UnitedHealth Group in a research note on Wednesday, January 28th. Morgan Stanley reduced their target price on UnitedHealth Group from $411.00 to $409.00 and set an “overweight” rating for the company in a report on Friday, January 23rd. Barclays lowered their price target on UnitedHealth Group from $391.00 to $327.00 and set an “overweight” rating on the stock in a research note on Friday, January 30th. Jefferies Financial Group decreased their price objective on UnitedHealth Group from $418.00 to $340.00 and set a “buy” rating on the stock in a report on Wednesday, January 28th. Finally, JPMorgan Chase & Co. dropped their target price on shares of UnitedHealth Group from $425.00 to $389.00 and set an “overweight” rating for the company in a report on Monday, February 2nd. One investment analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating, eight have assigned a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $372.13.

UnitedHealth Group Price Performance

NYSE:UNH opened at $259.15 on Monday. The stock has a 50 day moving average price of $290.39 and a 200 day moving average price of $322.26. The stock has a market cap of $235.23 billion, a PE ratio of 19.65, a P/E/G ratio of 1.19 and a beta of 0.41. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.79 and a current ratio of 0.79. UnitedHealth Group Incorporated has a one year low of $234.60 and a one year high of $606.36.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, January 27th. The healthcare conglomerate reported $2.11 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.09 by $0.02. UnitedHealth Group had a return on equity of 14.79% and a net margin of 2.69%.The business had revenue of $113.73 billion during the quarter, compared to the consensus estimate of $113.38 billion. During the same period last year, the company earned $6.81 EPS. The company’s revenue for the quarter was up 12.3% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. Equities research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 17th. Stockholders of record on Monday, March 9th were issued a dividend of $2.21 per share. The ex-dividend date was Monday, March 9th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 3.4%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 67.02%.

UnitedHealth Group Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.